首页> 外国专利> Gypenoside LXXV A pharmaceutical composition for preventing or treating cervical cancer comprising gypenoside LXXV

Gypenoside LXXV A pharmaceutical composition for preventing or treating cervical cancer comprising gypenoside LXXV

机译:绞股蓝皂甙LXXV用于预防或治疗宫颈癌的药物组合物,包含绞股蓝皂甙LXXV

摘要

The present invention relates to a pharmaceutical composition for preventing or treating cervical cancer comprising Gypenoside LXXV or a pharmaceutically acceptable salt thereof as an active ingredient; to a method of preventing or treating cervical cancer comprising a step of administering the pharmaceutical composition to a non-human organism; to a functional health food composition for preventing or alleviating cervical cancer comprising Gypenoside LXXV as an active ingredient; and a feed composition for preventing or alleviating cervical cancer comprising Gypenoside LXXV as an active ingredient. Since the composition comprising Gypenoside LXXV of the present invention is naturally-derived and shows an anti-cancer effect similar to ginsenoside Rg3(S), which is commercially available and clinically applied, the composition comprising Gypenoside LXXV may be utilized effectively and safely to prevent and treat cervical cancer.
机译:本发明涉及一种以人参皂苷LXXV或其药学上可接受的盐为有效成分的预防或治疗子宫颈癌的药物组合物。预防或治疗子宫颈癌的方法,包括将药物组合物施用于非人类有机体的步骤;用于预防或减轻子宫颈癌的功能性保健食品组合物,其包含绞股蓝皂苷LXXV作为活性成分;预防或减轻子宫颈癌的饲料组合物,其含有绞股蓝皂苷LXXV作为有效成分。由于本发明的包含人参皂苷LXXV的组合物是天然来源的并且显示出类似于人参皂苷Rg3(S)的抗癌作用,其可商购并在临床上使用,因此可以有效且安全地利用包含人参皂苷LXXV的组合物以预防并治疗子宫颈癌

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号